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Abstract 
Purpose: Smokers have increased denture stomatitis caused primarily by Candida albicans.  
The primary aim of this study was to demonstrate the impact of a wide range of nicotine and 
cigarette smoke condensate (CSC) concentrations on biofilm formation and metabolic activity 
of C. albicans on acrylic denture material. 
Materials and Methods: C. albicans (ATCC strain 10231) was used. Standardized denture 
acrylic (PMMA) samples (total of 135 samples) were incubated with C. albicans and exposed 
to nicotine and CSC at different concentrations (0, 0.25, 0.5, 1, 2, 4, 8, 16 and 32 mg/ml) and 
(0, 0.25, 0.5, 1, 2 and 4 mg/ml), respectively. For each experiment, 3 samples per nicotine and 
CSC concentration and a total of 45 specimens (27 specimens for the nicotine- and 18 
specimens for the CSC-treated samples) were used and they were selected randomly for each 
group. The control group consisted of 0 mg/ml of nicotine or CSC. The viability of C. albicans 
was measured using spiral plating on blood agar plates. The effect of nicotine and CSC 
concentrations on planktonic cells was were measured using a microplate reader. Metabolic 
activity of 24 h old established C. albicans biofilm exposed to nicotine and CSC for 24 h in 
microtiter plates was determined using a 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-carboxanilide (XTT) reduction assay.  
Results: The viability of C. albicans increased concomitant with increasing concentrations of 
CSC and nicotine, particularly at 0.5 and 2 mg/ml, respectively.  Concentrations of CSC and 
nicotine above this resulted in an inhibitory effect on C. albicans viability.  CSC and nicotine 
at 4 and 16 mg/ml, respectively, increased C. albicans biofilm metabolic activity. 
Conclusion: Nicotine and CSC up to certain concentrations caused increases in biofilm 
formation, metabolic activity, viability and planktonic cell absorbance of C. albicans. This in-
vitro study demonstrates the effectiveness of tobacco on promoting the growth of C. albicans 
and suggests their potential contributing factor in C. albicans biofilm related infections in 
smokers. 
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1. Introduction: 
             Fungi are eukaryotic organisms and can exist in two forms: yeast, or filamentous 
fungi.1 In addition, they can be a combination of these two, which are called dimorphic fungi 
such as Candida albicans. The oral environment contains many microorganisms including 
bacteria and fungi; C. albicans is found in 30-50% of the population.1  In general, as a person 
ages, the rate of C. albicans carriage increases. C. albicans is an opportunistic microorganism, 
which means that it is harmless in a normal oral environment, but if an imbalance in the oral 
flora occurs for whatever reason, C. albicans may colonize and cause infection.1 In order for C. 
albicans to initiate infection, it needs to adhere to host surfaces facilitated by fungal surface 
components such as the C3d receptor, or saccharine and mannoprotein in the C. albicans cell 
wall.1 Some additional reported C. albicans adhesins include Hwp1, Als5p, and Als1p.  These 
are members of a group of proteins called glycosylphatidylinositol-dependent cell wall proteins 
(GPI-CWP).1 These proteins have two termini; the N- terminal signal peptide peptide and the 
C- terminal that facilitates the attachment to cell wall glucan. The agglutinin-like sequence 
(ALS) family of C. albicans includes eight genes that encode several large cell-surface 
glycoproteins.2 The large family of ALS genes in C. albicans was found to consist of putative 
adhesins that adhere to endothelial, epithelial and extracellular matrix proteins of the host 
surface.3-5 C. albicans uses these adhesins to adhere to saliva-coated surfaces, such as 
prostheses (i.e., dentures). In addition, it was concluded by Hazen and co-workers that surface 
proteins on C. albicans attached to hydrophobic surfaces like dental materials.6 
                 Fungal infections are common in patients with various systemic conditions.7,8 
Patients who are at high risk include those with cancer who are undergoing 
immunosuppressive chemotherapy, especially if this treatment is causing neutropenia. In these 
patients, mucosal colonization with C. albicans has been found to be associated with increased 
incidence of systemic candidiasis.9 Many studies indicate that the prevalence of C. albicans 
varies widely, and a variety of factors seem to affect the prevalence.  One factor is denture 
wearing; 56% of elderly denture wearers are prone to C. albicans infection1, which is the 
leading microorganism in denture stomatitis. Denture stomatitis is a pathological condition of 
the soft tissue of the maxilla, typically covered by a denture, and is caused by trauma from ill-
fitting dentures, xerostomia, psychological factor, allergy, denture cleanliness resulting in C. 
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albicans colonization of denture acrylic material.10,11 The most widely used classification of 
denture stomatitis is the Newton classification that is based on the severity of the condition. 
Based on the Newton classification there are three types of denture stomatitis: (1) pinpoint 
hyperaemic foci; (2) diffuse hyperaemia of the denture supporting tissue; and  (3) papillary 
hyperplasia.12 
               Another major factor that is related to the prevalence of C. albicans is smoking, 
however the exact effect of smoking on the oral microflora including C. albicans is not yet 
clear. Many studies found no difference in the prevalence of C. albicans between smokers and 
non-smokers and concluded that smoking did not increase or decrease the oral mycotic 
flora.13,14,17,18 Beasley (1969) reported that smoking was not the causative factor of oral 
candidiasis.15 However, Arendorf and Walker in 1980 found that smoking significantly 
increased the carriage rate of C. albicans by 70%, while the rate in non-smokers was increased 
by 30%.16 Moreover, Tapper-Jones et al.19 examined diabetics and healthy subjects of the same 
age, sex, dental status and smoking habits, and observed that smoking increased the candidal 
carrier rate in both diabetic and healthy patients. In a recent in vitro study by Semlali et al.20  
on the effect of cigarette smoke condensate (CSC) on C. albicans, generated by complete 
burning of commercial cigarettes in an in house smoking machine where 1 cigarette provides up 
to 1 mg of nicotine and 4 mg of CSC, it was concluded that C. albicans adhesion, growth and 
biofilm formation increases with exposure to CSC. The study, however, had limitations in that 
they used glass slides to measure C. albicans adhesion and did not use acrylic material 
specimens. Furthermore, Baboni et al. 21 focused only on the attachment of C. albicans to the 
acrylic surface and did not measure biofilm formation.  Both are important differences as the 
yeast may attach in a different manner depending on the surface used and biofilm formation is 
much more complicated than simple attachment. 
               The combination of the two factors, smoking and denture wearing, was found to 
increase the candidal carriage in the oral cavity, which is the leading microorganism in denture 
stomatitis.22 The mechanism by which smoking may affect C. albicans has not yet been 
established. However, several researchers have provided hypotheses. One of the hypotheses is 
that smoking may cause localized epithelial alterations, which may expedite candidal 
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colonization. A second hypothesis is that smoking may provide some type of nutrition for C. 
albicans.22 
               The hypothesis of this study was that CSC and nicotine will increase C. albicans 
metabolic activity and biofilm formation of this opportunistic microorganism on denture 
acrylic material. According to previous studies from this laboratory using Streptococcus 
mutans, increased biofilm formation and metabolic activity at 1 mg/ml of nicotine and 0.5 
mg/ml of CSC was observed.23,24 The primary aim of this study was to demonstrate the impact 
of a wide range of nicotine and CSC concentrations on biofilm formation and metabolic 
activity of C. albicans on acrylic denture material. 
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2. Materials and Methods: 
2.1 Yeast and media: 
C. albicans was obtained from the American Type Culture Collection (ATCC 10231). C. 
albicans cells were inoculated into 5 ml of yeast-peptone-dextrose (YPD) broth medium (1% 
w/v yeast extract, 2% w/v peptone, 2% w/v dextrose; Fisher Scientific, Newark, DE, USA).  
Nicotine was purchased from Sigma Chemical Co., St. Louis, MO.  CSC was purchased from 
Murty Pharmaceuticals, Lexington, KY and was made by burning five cigarettes in an in house 
smoking device and concentrated in 100 ml of water at the end of this device. Approximately 
2.4% of the CSC concentration is nicotine and the remainder of the CSC consists of the other 
4000 components of cigarette smoke. 
2.2 PMMA specimen preparation: 
Acylic specimens were made using a thermoplastic sheet of 2 mm thickness. This sheet was 
flasked with dental stone (Microstone, Whip Mix), packed with Polymethacrylate Lucitone 199 
and cured by heating water for 8 h following the manufactor’s instructions. Once cured, it was 
removed from the flask and placed in an ultrasonic to remove stone remnants. Specimens were 
cut to a size of 8 mm x 8 mm with an automatic saw machine. The total number of specimens 
fabricated was 135.  For each experiment, 3 specimens per concentration and a total of 45 
specimens (27 specimens for nicotine- and 18 specimens for the CSC-treated samples) were 
used and they were selected randomly for each group . 
2.3 Biofilm formation on the acrylic samples: 
The acrylic samples were sterilized in 70% ethanol for 5 min and rinsed with sterile water and 
then placed in sterile 6 well tissue culture plates. Three specimens were placed in each well 
with 50 µl from an overnight yeast culture.  The wells were exposed to nicotine and CSC in 3 
ml of YPD at different concentrations (0, 0.25, 0.5, 1, 2, 4, 8, 16 and 32 mg/ml) and (0, 0.25, 
0.5, 1, 2 and 4 mg/ml), respectively. The 0 mg/ml nicotine or CSC group served as control 
groups. The plates were incubated for 48 h at 37oC in 5% CO2. The acrylic samples were 
removed from the wells and placed in 1 ml of sterile saline in a 15 ml centrifuge tube.  The 
attached biofilm were dislodged by sonication for 10 sec followed by vortexing for 10 sec. The 
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viability of C. albicans biofilm was measured using spiral plating on blood agar plates at 2 
dilutions (1:10 and 1:1000). Plates were incubated for 48 h at 37oC in 5% CO2.  The yeast 
colonies were counted by an automated colony counting instrument (Synbiosis, Inc., Frederick, 
MD, USA) using specialized Windows – based software which calculated the numbers of 
colony forming units (CFU)/ml.  
In order to determine the relative amount of planktonic growth the planktonic cells which were 
not attached to acrylic specimens were measured at 595 nm using a microplate reader 
(Molecular Devices, Sunnyvale, CA, USA). The effect of nicotine and CSC concentrations on 
planktonic cells was determined by pipetting 120 µl of the planktonic cell suspension from 
each well into a fresh 96 well microtiter plate and measuring the absorbance at 595 nm.  
2.4 Biofilm metabolic activity: 
C. albicans biofilm was established by incubating 10 µl of a C. albicans overnight culture in 
190 µl of YPD without CSC or nicotine to allow biofilm to grow in sterile 96-well microtiter 
plates for 24 h at 37°C. The biofilm was washed with sterile saline. These wells were exposed 
to nicotine and CSC in YPD at different concentrations (0, 0.25, 0.5, 1, 2, 4, 8, 16 and 32 
mg/ml) and (0, 0.25, 0.5, 1, 2 and 4 mg/ml), respectively, in quadruplicate for 24 h at 37°C.  
The metabolic activity of C. albicans was calculated using a method described by Pierce et al. 
25,26, by reduction of 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-carboxanilide 
(XTT) by biofilm cells into a water soluble orange compound.  XTT was prepared as a 
saturated solution, filtered, aliquoted and stored at -70°C.  Before assay this solution was 
thawed and menadione was added to the final concentration. The XTT/menadione solution was 
added to the prewashed biofilm, the plate was incubated in the dark for 2 h at 37°C and the 
color change of these plates was measured using a spectrophotometer (Molecular Devices, 
Sunnyvale, CA, USA) at 490 nm. 
2.5 Statistical analysis: 
The effect of each concentration of nicotine and CSC was measured in triplicate and each 
experiment was repeated three times. One-way ANOVAs (with a random effect for 
experiment) were performed to compare the concentrations of CSC or nicotine for differences 
in absorbance, CFU and metabolic activity. Due to non-normality, a natural log transformation 
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was used prior to analysis. Pair-wise comparisons between groups were made using Fisher’s 
Protected Least Significant Differences to control the overall significance level at 5%. 
Distribution of the data was examined and a transformation of the data was used. The study 
had 80% power to detect a 3.5x difference in CFU/mL between any groups.  The calculations 
assumed two-sided tests each conducted at a 5% significance level. All data were expressed as 
mean values with the corresponding standard errors of the mean.  
 
 
3. Results: 
The viability of C. albicans was significantly increased (p<0.05) concomitant with increasing 
concentrations of nicotine up to 2 mg/ml (mean value 5×107 and SD 2×107) and CSC up to 0.5 
mg/ml (mean value 4×107 and SD 2×107) (Fig. 1) from the mean of ?? and SD of ?? at 0 mg/ml 
of nicotine.  However, increasing the concentrations beyond these levels resulted in a 
significant inhibitory effect on C. albicans viability. Using higher concentrations of nicotine (4, 
8, 16 and 32 mg/ml) (mean value 2×106 , 3×105 , 102, 0) and CSC (1, 2 and 4 mg/ml) (mean 
value 1×107, 9×105, 6×105) resulted in significant inhibition of C. albicans viability. 
To provide a more quantitative assessment of cellular activity of established C. albicans 
biofilm in the presence or absence of nicotine and CSC, the ability of yeast to reduce XTT was 
measured (Fig. 2). The results demonstrated that nicotine at 16 mg/ml (mean value 3.4 and SD 
0.7) and CSC at 4 mg/ml (mean value 1.1 and SD 0.1), significantly increased C. albicans 
biofilm metabolic activity. However, increasing the concentrations above these levels resulted 
in a decline of C. albicans metabolic activity. Higher concentrations of nicotine at 32 mg/ml 
(mean value 3 and SD 0.7) and CSC at 8 mg/ml (mean value 1 and SD 0.1) resulted in a 
significant inhibitory effect on C. albicans metabolic activity. 
Planktonic cell absorbance results with different nicotine concentrations (0, 0.25, 0.5, 1, 2, 4, 8, 
16 and 32 mg/ml) were consistent with C. albicans viability at similar concentrations of 
nicotine (Fig. 3). Increasing planktonic cell absorbance was observed with increasing 
concentrations of nicotine. As the concentration of nicotine increased from 0 mg/ml (mean 
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value 0.3 and SD 0.05) up to 2 mg/ml (mean value 0.4 and SD 0.03), the measurement of 
planktonic cell absorbance increased as well and then with higher concentrations of nicotine 
from 2 mg/ml (mean value 0.4 and SD 0.03) up to 32 mg/ml (mean value 0.02 and SD 0.01), 
the planktonic cell absorbance started to decline.  However, planktonic cell absorbance results 
with different concentrations of CSC (0, 0.25, 0.5, 1, 2, 4 and 8 mg/ml), was significantly 
different than the viability of C. albicans with the various CSC concentrations. Planktonic cell 
absorbance continued to increase with increasing concentrations of CSC up to 8 mg/ml (mean 
value 0.9 and SD 0.07). 
Overall, there were significant differences between the various CSC concentrations for C. 
albicans absorbance and CFU. Furthermore, there were significant differences between the 
concentrations of nicotine for C. albicans absorbance, CFU, and metabolic activity.  
 
 
 
4. Discussion: 
1. Fungal infections are common in patients with various systemic conditions.7,8 Many 
studies demonstrate that the prevalence of C. albicans varies widely, and a variety of 
factors seem to affect the prevalence.  One factor related to the prevalence of C. 
albicans is smoking, however the exact effect of smoking on the oral microflora 
including C. albicans is not yet clear. The present study demonstrated that nicotine and 
CSC at certain concentrations had an impact by increasing C. albicans viability, 
planktonic cell absorbance and cellular metabolic activity. Then at specific higher 
nicotine and CSC concentrations the impact starts to be inhibitory by reducing C. 
albicans viability, planktonic cell absorbance and cellular metabolic activity. These 
results are in agreement with earlier data that indicated the impact of smoke and CSC 
on C. albicans.19,20,21 However, these results were in contrast to several studies which 
did not find any relationship between smoke and the prevalence of C. 
albicans.13,14,15,17,18 Nicotine has been demonstrated to stimulate microbial biofilm 
formation, which increases the risk of oral health problems. Nicotine enhances biofilm 
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formation of different microorganisms in the oral cavity including L. casei, A. viscosus, 
A. naeslundii, E. faecalis and C. albicans. In addition, many studies indicated that 
nicotine and CSC increase the adhesion of C. albican, S. mutans, and S. pneumonaiae 
to hard and soft oral surfaces.24   The present study demonstrated that an increase in 
nicotine or CSC concentrations resulted in a decrease of C. albicans viability and 
increasing nicotine concentrations resulted in a decrease in planktonic cell absorbance 
while the opposite was reported for CSC.  These results are possibly due to other 
components of CSC than nicotine. All of these data support the effect of nicotine on 
oral biofilm and enhancement of bacterial and fungal growth. 
Approximately 1 mg of nicotine is absorbed with each smoked cigarette.27 The nicotine 
concentrations used in the present study were (0, 0.25, 0.5, 1, 2, 4, 8, 16 and 32 mg/ml). These 
concentrations are physiologically relevant to the smoker. After smoking, nicotine accumulates 
in oral biofilm but there is no evidence indicating the total nicotine accumulation in the dental 
plaque of smokers. 
Although there is no direct association that can be ascribed clinically to changes in the 
absorbances observed in the biofilm, planktonic or metabolic activity measurements, it is 
assumed that reduced measurements may be correlated with reduced C. albicans attached to 
the denture material and subsequently there should be less inflammation and therefore less 
denture stomatitis disease. 
 
CSC contains several carcinogenic materials other than nicotine such as heterocyclic amine, 
and 2-amlno-1-methyl-6-phenylimidazo[4,5-b] (PhIP) compounds. The PhIP compounds 
including benzene, cadmium, arsenic, nickel, chromium, 2-naphthylamine, vinyl chloride and 
beryllium, which might explain the differences in biofilm formation between nicotine and CSC 
observed in this study. All of these components in CSC may have an impact on C. albicans 
growth or inhibition.28,29 The impact of CSC on C. albicans was reported earlier by Baboni et 
al. which indicated increasing C. albicans cell adhesion was associated with increasing CSC 
concentrations. But as the CSC concentration increased up to 50% it started to have an 
inhibitory effect on cell adhesion.20 In addition, CSC increased the adhesion of C. albicans on 
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all non-metal materials including acrylic resin.30 CSC can be a contributing factor to oral 
candidiasis due to increasing the virulence of C. albicans with increasing the secretion of 
histolytic enzymes.30 Appropriate further studies will be necessary to investigate the 
mechanism that led to the results reported here between C. albicans and CSC. 
Some of the limitations of this study were that this was a controlled in-vitro study and in the 
oral environment we have many variables that it is difficult to duplicate in the lab. It would be 
more beneficial if clinical isolates of C. albicans in saliva samples were taken directly from the 
smokers. Another limitation was that at specific nicotine and CSC concentrations the impact 
was inhibitory by reducing C. albicans viability, planktonic cell absorbance and cellular 
metabolic activity but the exact mechanism is still unknown and further investigations are 
needed to clarify the inhibitory effect.   
As a result of increased C. albicans metabolic activity and biofilm formation of this 
opportunistic microorganism on denture acrylic material correlated with increased 
concentrations of CSC and nicotine up to a certain dose, the hypothesis of this study was 
accepted. 
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5. Conclusion 
Within the limitations of this study the following conclusions can be drawn: 
1. Increased growth of C. albicans in the presence of CSC and nicotine suggests that they 
may be potential contributing factors to C. albicans biofilm related infections in 
smokers. 
2. Nicotine and CSC caused a dose–dependent increase in the biofilm formation, 
metabolic activity, the viability and planktonic cell absorbance of C. albicans. 
3. High concentrations of CSC and nicotine resulted in inhibition of the viability of C. 
albicans. 
 
6. Clinical Significance  
From a clinical perspective, the results from the current study emphasized the importance of 
communicating with the patient regarding the effect of smoking on the oral environment. In 
addition, dentists must be aware that some strategies must be applied to reduce the risk of 
microbial colonization, such as the importance of maintaining good oral hygiene particularly if 
the patient is wearing a dental appliance that is made of acrylic resin and the importance of 
regular dental visits. 
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Figure legends 
Figure 1.  The viability of C. albicans incubated with different concentrations of (A) nicotine 
and (B) CSC after 24 h at 37°C. The data are expressed as mean colony forming units 
(CFU)/ml ± S.E.M.  Asterisks indicate significant differences (p< 0.05) when compared with 
the no nicotine/CSC groups. 
Figure 2.  Biofilm metabolic activity of C. albicans incubated with different concentrations of 
(A) nicotine and (B) CSC after 48 h at 37°C. The data are expressed as mean absorbance (490 
nm) ± S.E.M.  Asterisks indicate significant differences (p< 0.05) when compared with the no 
nicotine/CSC groups. 
Figure 3.  Planktonic cell absorbance of C. albicans incubated with different concentrations of 
(A) nicotine and (B) CSC after 48 h at 37°C. The data are expressed as mean absorbance (595 
nm) ± S.E.M. Asterisks indicate significant differences (p< 0.05) when compared with the no 
nicotine/CSC groups. 
 
 
